Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 18, 2021 01:00 ET | Source: VALNEVA

Valneva Reports Nine-Month 2021 Revenue and Cash

Strong financial position Cash and cash equivalents of €247.9 million at the end of September 2021 Reflects $107.6 million of gross proceeds raised in a US IPO and placement in Europe in the second...
November 15, 2021 11:45 ET | Source: VALNEVA

Valneva to Present its Chikungunya Vaccine Candidate at the ASTMH 2021 Annual Meeting

Saint-Herblain (France), November 15, 2021 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced it will present its Chikungunya vaccine candidate, VLA1553, on...
November 15, 2021 11:45 ET | Source: VALNEVA

Valneva présentera son candidat vaccin contre le chikungunya lors de la conférence ASTMH 2021

Saint-Herblain (France), le 15 novembre 2021 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), société spécialisée dans les vaccins, annonce aujourd’hui qu’elle présentera son candidat vaccin contre...
November 10, 2021 06:22 ET | Source: VALNEVA

Valneva annonce l'approbation par la Commission européenne d’un accord d'achat anticipé d’un maximum de 60 millions de doses du vaccin inactivé contre la COVID-19, VLA2001

Saint-Herblain (France), le 10 novembre 2021 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), société spécialisée dans les vaccins, annonce aujourd’hui que la Commission européenne (EC) a approuvé un...
November 10, 2021 06:22 ET | Source: VALNEVA

Valneva Announces European Commission Approval of Advance Purchase Agreement for up to 60 Million Doses of Inactivated COVID-19 Vaccine VLA2001

Saint-Herblain (France), November 10, 2021 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that the European Commission (“EC”) has approved an agreement...
November 08, 2021 11:40 ET | Source: VALNEVA

Valneva to Present and Hold Investor Meetings at the Jefferies London Healthcare Conference

Saint-Herblain (France), November 8, 2021 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that its senior management will present and participate in...
November 08, 2021 11:40 ET | Source: VALNEVA

Valneva fera une présentation et participera à des réunions investisseurs lors de la conférence Jefferies à Londres

Saint-Herblain (France), le 8 novembre 2021 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), société spécialisée dans les vaccins, annonce aujourd’hui que des membres de son équipe dirigeante...
November 04, 2021 13:00 ET | Source: VALNEVA

VALNEVA : Déclaration d’actions et de droits de vote - Situation intermédiaire au 2 novembre 2021 (et information au 31 octobre 2021)

VALNEVA Déclaration d’actions et de droits de vote Situation intermédiaire au 2 novembre 2021 (et information au 31 octobre...
November 04, 2021 13:00 ET | Source: VALNEVA

VALNEVA: Declaration of shares and voting rights - Interim status at November 2, 2021 (and information at October 31, 2021)

VALNEVA Declaration of shares and voting rights Interim status at November 2, 2021 (and information at October 31,...
November 03, 2021 02:00 ET | Source: VALNEVA

Valneva Announces Closing of Approximately $102.0 Million Global Offering

Saint-Herblain (France), November 3, 2021 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA) (the “Company”), a specialty vaccine company, announced today the closing which occurred on November 2,...